CVS Health has delivered four consecutive earnings beats with an average positive surprise near 17% and converts net income to free cash flow at a ratio of roughly 1.8 times. However, the stock has reached its near-term price target with zero headroom remaining and a reward-to-risk ratio at essentially zero, overall quality sits below the minimum threshold at 3.3 out of 10, and an active legal risk event has triggered a gate failure alongside a dividend safety warning.
Thesis pillars
- Quality Below Minimum Floor↓Deteriorating
- Consistent Earnings Outperformance→Stable
- Strong Free Cash Flow Conversion→Stable
- +1 more pillar — see the Why tab for full reasoning
CVS Health Corporation (CVS) Stock Analysis
Catalyst-Driven edge
Healthcare · Healthcare Plans
Sell if holding. Engine safety override at $90.39: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 2.2:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality.
CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan members, and Aetna insurance serving ~37 million members across four segments. Revenue comes from pharmacy dispensing, PBM service fees, and health insurance... Read more
Sell if holding. Engine safety override at $90.39: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 2.2:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.7/10, moderate confidence.
Passes 6/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, earnings proximity 20d clear, semi cycle peak clear, materials cycle peak clear). Fails on news legal. Suitability: moderate.
Recent developments
updated 2026-10-15Recent Developments — CVS Health Corporation
Latest news
- NEWS CVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions — benzinga Oct 14, 2026 negative
- NEWS QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins — benzinga Oct 13, 2026 neutral
- NEWS CVS Agrees To Pay $315M For Illegally Filling Unlawful Opioid Prescriptions And For Submitting False Claims To The Feder — benzinga Oct 13, 2026 negative
- NEWS 'CVS agrees to pay $315 million to settle Justice Department case over opioid prescriptions' - Associated Press — benzinga Oct 13, 2026 negative
- NEWS Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $112 — benzinga Oct 12, 2026 positive
Generated 2026-10-15T11:37:20Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWCustomerU.S. federal government20%10-K Item 1: 'Health Care Benefits segment revenues from the federal government accounted for approximately 20% of the Company's consolidated total revenues in 2025'
Material Events(8-K, last 90d)
- 2026-05-18Item 5.02LOWCVS Health 2026 Annual Meeting (May 14, 2026): stockholders approved the 2026 Incentive Compensation Plan, replacing the expiring 2017 plan. No officer departures or director elections reported in this item.SEC filing →
- 2026-03-19Item 5.02LOWBoard elected John E. Gallina (former CFO of Elevance Health) as director, effective March 19, 2026. Routine board addition; no officer departure cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $90.39: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 2.2:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $85.49. Score 5.7/10, moderate confidence.
Take-profit target: $103.93 (+15.0% upside). Prior stop was $85.49. Stop-loss: $85.49.
Quality below floor (3.4 < 4.0).
CVS Health Corporation trades at a P/E of 23.8 (forward 10.6). TrendMatrix value score: 7.8/10. Verdict: Sell.
33 analysts cover CVS with a consensus score of 4.1/5. Average price target: $115.
What does CVS Health Corporation do?CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan...
CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan members, and Aetna insurance serving ~37 million members across four segments. Revenue comes from pharmacy dispensing, PBM service fees, and health insurance premiums; federal government programs represented ~20% of consolidated 2025 revenues.